Evidence map›Paper›PMID 26899457›Full record

ArticleThe Analyst2016

Microfluidic devices with templated regular macroporous structures for HIV viral capture.

Krissada Surawathanawises, Kathryn Kundrod, Xuanhong Cheng

Open access · greenAbstract read
In one paragraph

Article in The Analyst, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.2field-weighted citation impact, top 45% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 6 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 2 countries.

Krissada SurawathanawisesDepartment of Materials Science and Engineering, Lehigh University, Bethlehem, PA 18015, USA.
Kathryn KundrodBioengineering Program, Lehigh University, Bethlehem, PA 18015, USA. xuc207@lehigh.edu.
Xuanhong ChengDepartment of Materials Science and Engineering, Lehigh University, Bethlehem, PA 18015, USA and Bioengineering Program, Lehigh University, Bethlehem, PA 18015, USA. xuc207@lehigh.edu.
Lehigh University · USBioengineering Center · RU

Funding

A Microfluidic Device for Label-free HIV Virion Count at Point of Care SettingsR21AI081638 · NIAID · LEHIGH UNIVERSITY · PI CHENG, XUANHONG · 2009 to 2010
$410k
NIAID NIH HHS 1R21AI081638NIAID NIH HHS R21 AI081638
6 · The paper itself

Abstract

There is a need to develop inexpensive, portable and easy-to-use devices for viral sample processing for resource-limited settings. Here we offer a solution to efficient virus capture by incorporating macroporous materials with regular structures into microfluidic devices for affinity chromatography. Two-dimensional simulations were first conducted to investigate the effects of two structures, a nanopost array and a spherical pore network, on nanoparticle capture. Then, the two structures were created in polymers by templating anodic aluminum oxide films and 3D close-packed silica particles, respectively. When the microdevices containing functionalized porous materials were tested for human immunodeficiency virus (HIV) isolation, capture efficiencies of 80-99% were achieved under a continuous flow. Comparatively, functionalized flatbed microchannels captured around 10% of HIV particles. As the characteristic dimensions of the nanostructures are tunable, such devices can be adapted for the capture of different submicron bioparticles. The high capture efficiency and easy-to-operate nature suit the needs of resource-limited settings and may find applications in point-of-care diagnostics.

Indexed as

Lab-On-A-Chip DevicesHEK293 CellsHIVHumansNanoparticlesNanotechnologyPolymethyl MethacrylatePolystyrenesPorosityVirionPolymethyl MethacrylatePolystyrenes

Identifiers

PMID26899457
PMCPMC4765901
OpenAlexW2268469564

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.